Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Famotidine vs Placebo for PONV Risk in Pediatric Emergency Surgery
NCT06211088Completed
- Sponsor
- Aswan University Hospital
- Start
- Aug 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in postoperative nausea and vomiting (PONV) comparing Famotidine with Placebo (2 arms). Primary endpoints: Difference of the gastric volume by quantitative measurements of gastric antrum and Postoperative Nausea and Vomiting. Started Aug 2024; status: completed.
02
Drugs
famotidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06211088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06211088.